ORK-6

N/A

Report date: 2026/01/30 18:00:13

Base Information

Drug NameORK-6
Drug Alias NameORK-6ORK6
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeuroinflammatory Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOrikine Bio SL
China Registration ClassN/A

Develop Information

Active CompaniesOrikine Bio SL
Inactive CompaniesN/A
Active IndicationsNeuroinflammatory Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A